{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:08:24Z","timestamp":1789787304250,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T00:00:00Z","timestamp":1726790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005040","name":"Bontius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.nucmedbio.2024.108952","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T20:32:00Z","timestamp":1726777920000},"page":"108952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Preoperative [18F]fluoro-PEG-folate PET\/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study"],"prefix":"10.1016","volume":"138-139","author":[{"given":"Isabeau A.","family":"Ciggaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne D.A.N.","family":"de Muynck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lioe-Fee","family":"de Geus-Oei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris H.P.","family":"van Velden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis D.","family":"de Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka M.","family":"Pereira Arias-Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wyanne A.","family":"Noortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Els L.","family":"van Persijn van Meerten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Dibbets-Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik J.F.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.","family":"Windhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander L.","family":"Vahrmeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge T.A.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja N.","family":"Gaarenstroom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.nucmedbio.2024.108952_bb0005","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/ijgo.13878","article-title":"Cancer of the ovary, fallopian tube, and peritoneum: 2021 update","volume":"155","author":"Berek","year":"2021","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0010","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2023.03.035","article-title":"Cytoreductive surgery for advanced epithelial ovarian cancer in the poly(ADP-ribose) polymerase inhibitors era-is it time for a new paradigm shift? A systematic review and meta-analysis","volume":"187","author":"Peters","year":"2023","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0020","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/S1470-2045(18)30566-7","article-title":"Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials","volume":"19","author":"Vergote","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0025","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.diii.2022.05.003","article-title":"The BUMPy road of peritoneal metastases in ovarian cancer","volume":"103","author":"Nougaret","year":"2022","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0030","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1007\/s00330-019-06524-x","article-title":"Diagnostic performance of imaging for the detection of peritoneal metastases: a meta-analysis","volume":"30","author":"van\u2019t Sant","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ygyno.2016.03.015","article-title":"Pattern of and reason for postoperative residual disease in patients with advanced ovarian cancer following upfront radical debulking surgery","volume":"141","author":"Heitz","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0040","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2016.01.022","article-title":"Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase","volume":"140","author":"Grabowski","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0045","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1245\/ASO.2006.08.021","article-title":"A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study","volume":"13","author":"Fagotti","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0050","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2015.07.095","article-title":"Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept","volume":"139","author":"Petrillo","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0055","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1200\/JCO.2016.69.2962","article-title":"Laparoscopy to predict the result of primary cytoreductive surgery in patients with advanced ovarian cancer: a randomized controlled trial","volume":"35","author":"Rutten","year":"2017","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.nucmedbio.2024.108952_bb0060","article-title":"Laparoscopy for diagnosing resectability of disease in women with advanced ovarian cancer","author":"van de Vrie","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0065","doi-asserted-by":"crossref","first-page":"341","DOI":"10.23736\/S0026-4806.19.06132-9","article-title":"Laparoscopy vs. laparotomy for advanced ovarian cancer: a systematic review of the literature","volume":"110","author":"Gueli Alletti","year":"2019","journal-title":"Minerva Med"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0070","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ejca.2017.06.010","article-title":"Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer","volume":"83","author":"Michielsen","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0075","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1136\/ijgc-2023-004592","article-title":"Predicting resectable disease in relapsed epithelial ovarian cancer by using whole-body diffusion-weighted MRI","volume":"33","author":"Dumont","year":"2023","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3892\/or.2021.8051","article-title":"Accuracy of MRI for diagnosing pelvic and para-aortic lymph node metastasis in cervical cancer","volume":"45","author":"Dezen","year":"2021","journal-title":"Oncol Rep"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41571-021-00548-3","article-title":"Fundamentals and developments in fluorescence-guided cancer surgery","volume":"19","author":"Mieog","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13402-011-0052-6","article-title":"The effect of chemotherapy on expression of folate receptor-alpha in ovarian cancer","volume":"35","author":"Crane","year":"2012","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0095","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ygyno.2013.03.024","article-title":"Folate receptor alpha (FRA) expression remains unchanged in epithelial ovarian and endometrial cancer after chemotherapy","volume":"130","author":"Despierre","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0100","first-page":"12","article-title":"Novel molecular targets for tumor-specific imaging of epithelial ovarian cancer metastases","author":"Muynck","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10555-014-9539-8","article-title":"Role of the folate receptor in ovarian cancer treatment: evidence, mechanism, and clinical implications","volume":"34","author":"Vergote","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ygyno.2019.07.010","article-title":"A phase II, multicenter, open-label trial of OTL38 injection for the intra-operative imaging of folate receptor-alpha positive ovarian cancer","volume":"155","author":"Randall","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0115","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1158\/1078-0432.CCR-15-2640","article-title":"A novel tumor-specific agent for intraoperative near-infrared fluorescence imaging: a translational study in healthy volunteers and patients with ovarian cancer","volume":"22","author":"Hoogstins","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0120","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1021\/mp500628g","article-title":"Folate receptor-targeted multimodality imaging of ovarian cancer in a novel syngeneic mouse model","volume":"12","author":"Ocak","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0125","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1007\/s11307-017-1049-y","article-title":"Development of a new folate-derived Ga-68-based PET imaging agent","volume":"19","author":"Brand","year":"2017","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0130","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/acs.molpharmaceut.5b00989","article-title":"Synthesis and preclinical evaluation of folate-NOTA-Al(18)F for PET imaging of folate-receptor-positive tumors","volume":"13","author":"Chen","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0135","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41598-020-57841-x","article-title":"First in man study of [18F]fluoro-PEG-folate PET: a novel macrophage imaging technique to visualize rheumatoid arthritis","volume":"10","author":"Verweij","year":"2020","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.nucmedbio.2024.108952_bb0140","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s11307-024-01922-0","article-title":"Challenges in pharmacokinetic modelling of [18F]fluoro-PEG-folate PET\/CT imaging in epithelial ovarian cancer patients","volume":"26","author":"Ruytenberg","year":"2024","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0145","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0150","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic intraperitoneal chemotherapy in ovarian cancer","volume":"378","author":"van Driel","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0155","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar4191","article-title":"Evaluation of the novel folate receptor ligand [18F]fluoro-PEG-folate for macrophage targeting in a rat model of arthritis","volume":"15","author":"Gent","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0160","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3390\/cancers14010191","article-title":"Folate transport and one-carbon metabolism in targeted therapies of epithelial ovarian cancer","volume":"14","author":"Wallace-Povirk","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0165","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s13046-019-1123-1","article-title":"Folate receptors and transporters: biological role and diagnostic\/therapeutic targets in cancer and other diseases","volume":"38","author":"Frigerio","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0170","series-title":"Tumor immune microenvironment in cancer progression and cancer therapy","first-page":"229","article-title":"Imaging the tumor microenvironment","author":"Abadjian","year":"2017"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0175","first-page":"8","article-title":"Updates on anticancer therapy-mediated vascular toxicity and new horizons in therapeutic strategies","author":"Hsu","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0180","first-page":"23","article-title":"Accuracy and reproducibility of the peritoneal cancer index in advanced ovarian cancer during laparoscopy and laparotomy","author":"Gouy","year":"2013","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.nucmedbio.2024.108952_bb0185","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1245\/s10434-020-08234-x","article-title":"The pathologic peritoneal cancer index (PCI) strongly differs from the surgical PCI in peritoneal metastases arising from various primary tumors","volume":"27","author":"Bhatt","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T03:48:05Z","timestamp":1734666485000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":37,"alternative-id":["S0969805124000787"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108952","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative [18F]fluoro-PEG-folate PET\/CT in advanced stage epithelial ovarian cancer: A safety and feasibility study","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108952"}}